ABBOTT LABORATORIES — Director's Dealing 2017

Mar 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-02-28

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-28	Common shares without par value	F	8740	$45.46	Disposed	58888	Direct
2017-02-28	Common shares without par value	S	10100	$45.015	Disposed	48788	Direct
2017-02-28	Common shares without par value	S	3055	$45.01	Disposed	45733	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	21	Indirect
Common shares without par value	63903	Indirect
Common shares without par value	2426	Indirect
Common shares without par value	12081	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2017.

F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F3: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F4: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.